"Pharmaceutical Headlines" 500 list announced that "medicine again record high these white horses but...

(2020/11/30) Novarma Adakveo rejected in the UK to prevent relapse sickle cell crisis; health insurance: how to fill the gap between product supply and demand for security; 200 million elderly people 40 million degenerative people This is Chinese's most needed and life-time insurance ... (Click on the title, available in the original article) Novarma Adakveo used to prevent relapsed sickle cell crisis in the UK was rejected According to British media reports, Novarma Adakveo (crizanlizumab) suffered a setback in the UK healthcare market, it failed to get recognition from the UK National Institute for Health and Clinical Optimization (NICE).
within Adakveo's listing license, cost watchdog NICE does not recommend that the drug be used to prevent relapsed sickle cell crises (or vascular obstructive crisis, VOCs) in patients aged 16 or older with sickle cell disease.
headlines: Adakveo may need more discounts to break into the UK sickle cell disease market.
"Diary of the Village" Health Insurance: How to fill the gap between product supply and protection demand In the outbreak, the health insurance market remained at nearly 20% growth rate, from the product structure, to millions of medical insurance-based short-term medical insurance has achieved rapid growth, but the growth rate of serious illness insurance has slowed significantly.
Because long-term insurance, which is dominated by serious illness insurance, accounts for 60% of the size of the health insurance market, even if short-term insurance has achieved high growth, health insurance growth in 2020 will still be much lower than in 2019, and growth in January-September 2020 has fallen to less than 18%, which is in sharp contrast to the growth rate of more than 30% in the same period last year.
: How to continue to improve sales models and channel communication is another important competitive factor.
the "E Drug Manager" 500 list announced that medicine again record high, but these white horses fell who fell the worst? Hurun Research Institute recently announced the 2020 China's top 500 private enterprises list.
, more pharmaceutical companies made the list, taking nearly 20 percent of the seats.
but behind this, but it is difficult to hide the fact that: the ranking of large pharmaceutical companies have fallen, a large number of innovative pharmaceutical companies straight up the cloud, have entered the list! Headline: Who can be China's first trillion-dollar pharmaceutical company? Eight o'clock health news: 200 million elderly 40 million de-energy population This is Chinese the most needed and life-time insurance 254 million people over 60 years of age, 40 million people without energy, these two huge figures suggest that the Chinese most urgently needed insurance - long-term care insurance.
it's also an insurance policy.
Recently, when the National Health Insurance Administration and the Ministry of Finance announced the addition of 14 pilot cities for long-term insurance, and to clarify its status as an independent insurance species, immediately rushed to the hot search, by public opinion as "social security sixth risk" title.
headlines: caregivers and carers are in despair.
The twists and turns of ketamine, a double-sided angel, also starts with cyclohexamine, an industrial product that has anaesthetic effect but is toxic and not suitable for use as an anaesthetic.
1950s, the war continued, especially when the United States launched the Vietnam War in 1955.
and good anesthetics have always been scarce, especially in those days.
a company called Park Davis, decided to develop anaesthetic.
: Benzene ring is not suitable for use as an anesthetic.
。